EICHORPublic-registry site landscape for NCT07750678, “Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy”, a Hereditary Corneal Dystrophy study sponsored by GenEditBio Limited. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07750678 (registry record) |
| Study title | Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy |
| Official title | A Multicenter, Phase I/II, Clinical Study to Evaluate the Safety, Tolerability and Efficacy of Intrastromal Injection of Genome-editing GEB-101 in Participants With TGFBI-related Corneal Dystrophy |
| Sponsor | GenEditBio Limited |
| Condition(s) | Hereditary Corneal Dystrophy; Corneal Abnormality; Corneal Dystrophies; Corneal Dystrophies, Hereditary |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 2 |
| Site countries | United States, China |
Patient-friendly overview of this study: eichor.com/study/NCT07750678.
Eichor generates a preliminary site-risk snapshot for NCT07750678 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
